The aptitude of Ropinirole to permeate the buccal tissue was tested using porcine mucosa mounted on Franz-type diffusion cells as ex vivo model. Drug permeation was also evaluated in presence of various penetration enhancers and in iontophoretic conditions. Ropinirole, widely used in treatment of motor fluctuations of Parkinson’s Disease, passes the buccal mucosa. Flux and permeability coefficient values suggested that the membrane does not appear a limiting step to the drug absorption. Nevertheless, an initial lag time is observed but the input rate can be modulated by permeation enhancement using Limonene or by application of electric fields. Absorption improvement was accompanied by the important reduction of the lag time; at once the time required to reach the steady state plasma concentration was drastically decreased. On the basis of these results we could assume that clinical application of Ropinirole by buccal delivery is feasible
De Caro, V., Giandalia, G., Siragusa, M.G., Sutera, F.M., Giannola, L.I. (2012). New prospective in treatment of Parkinson’s disease: Studies on permeation of ropinirole through buccal mucosa. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 429(1-2), 78-83 [10.1016/j.ijpharm.2012.03.022].
New prospective in treatment of Parkinson’s disease: Studies on permeation of ropinirole through buccal mucosa
DE CARO, Viviana;GIANDALIA, Giulia;SIRAGUSA, Maria Gabriella;SUTERA, Flavia Maria;GIANNOLA, Libero Italo
2012-01-01
Abstract
The aptitude of Ropinirole to permeate the buccal tissue was tested using porcine mucosa mounted on Franz-type diffusion cells as ex vivo model. Drug permeation was also evaluated in presence of various penetration enhancers and in iontophoretic conditions. Ropinirole, widely used in treatment of motor fluctuations of Parkinson’s Disease, passes the buccal mucosa. Flux and permeability coefficient values suggested that the membrane does not appear a limiting step to the drug absorption. Nevertheless, an initial lag time is observed but the input rate can be modulated by permeation enhancement using Limonene or by application of electric fields. Absorption improvement was accompanied by the important reduction of the lag time; at once the time required to reach the steady state plasma concentration was drastically decreased. On the basis of these results we could assume that clinical application of Ropinirole by buccal delivery is feasible
| File | Dimensione | Formato | |
|---|---|---|---|
|
Int J Pharm 429 (2012) 78-83.pdf
Solo gestori archvio
Descrizione: Articolo principale
Dimensione
277.47 kB
Formato
Adobe PDF
|
277.47 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
